Drug intelligence / Profile preview

MyCiss Plus

Development stage
Unknown
Lead developer
Elbrit Life Sciences
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

MyCiss Plus is an oral orthopedic nutritional supplement developed by Elbrit Life Sciences. It is formulated as a tablet containing a combination of Cissus quadrangularis extract, calcium phosphate, ergocalciferol (Vitamin D2), and Withania somnifera (Ashwagandha) extract. The supplement is designed to support bone and joint health, promote bone mineralization, accelerate fracture healing, and reduce joint pain. Cissus quadrangularis and Withania somnifera extracts provide osteogenic, anti-inflammatory, and chondroprotective effects, while calcium phosphate and ergocalciferol supply essential minerals and vitamins to enhance bone mineral density and prevent osteoporosis.

Brand names
MyCiss Plus
Other names
Myciss Plus
02

Targets

CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on MyCiss Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyCiss Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call